Torbjörn Wärnheim
Nessuna posizione attualmente
Patrimonio netto: 14 218 $ in data 30/06/2024
Profilo
Torbjörn Wärnheim worked as an Executive VP and Manager of Research & Development at Moberg Pharma AB from 2019 to 2021.
He also worked as a Vice President of Research & Development at Fresenius Kabi AB.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
OLINK HOLDING AB
0.00% | 05/02/2024 | 558 ( 0.00% ) | 14 218 $ | 30/06/2024 |
Precedenti posizioni note di Torbjörn Wärnheim
| Società | Posizione | Fine |
|---|---|---|
| MOBERG PHARMA AB | Direttore Tecnico/Scientifico/R&S | 01/09/2021 |
Fresenius Kabi AB
 Fresenius Kabi AB Medical SpecialtiesHealth Technology Fresenius Kabi AB specializes in clinical nutrition, infusion therapy, and medical technology. It offers products for the collection and treatment of blood components and for the treatment of patient blood through therapeutic apheresis. The firm also develops products with a focus on oncology and autoimmune diseases. The company is headquartered in Uppsala, Sweden. | Direttore Tecnico/Scientifico/R&S | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| MOBERG PHARMA AB | Health Technology |
| Aziende private | 1 |
|---|---|
Fresenius Kabi AB
Fresenius Kabi AB Medical SpecialtiesHealth Technology Fresenius Kabi AB specializes in clinical nutrition, infusion therapy, and medical technology. It offers products for the collection and treatment of blood components and for the treatment of patient blood through therapeutic apheresis. The firm also develops products with a focus on oncology and autoimmune diseases. The company is headquartered in Uppsala, Sweden. | Health Technology |
- Borsa valori
- Insiders
- Torbjörn Wärnheim
